Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
262.08M | 251.43M | 223.93M | 165.09M | 195.79M | Gross Profit |
31.70M | 31.45M | 29.92M | 20.92M | 23.33M | EBIT |
1.18M | 4.50M | 5.17M | -206.00K | 944.00K | EBITDA |
3.86M | 6.92M | 7.54M | 4.55M | 3.16M | Net Income Common Stockholders |
-1.20M | 2.52M | 3.00M | 1.41M | -252.00K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
438.00K | 4.23M | 2.76M | 5.74M | 1.48M | Total Assets |
99.54M | 100.03M | 84.49M | 94.82M | 96.28M | Total Debt |
35.80M | 33.58M | 27.23M | 39.25M | 45.11M | Net Debt |
35.36M | 29.35M | 24.47M | 33.51M | 43.63M | Total Liabilities |
70.81M | 68.37M | 49.76M | 67.23M | 69.89M | Stockholders Equity |
28.74M | 31.66M | 34.73M | 27.59M | 26.38M |
Cash Flow | Free Cash Flow | |||
-2.46M | 3.33M | 553.00K | 6.33M | -1.78M | Operating Cash Flow |
119.00K | 4.24M | 3.39M | 6.72M | -802.00K | Investing Cash Flow |
-2.33M | -716.00K | -2.65M | -209.00K | -795.00K | Financing Cash Flow |
-1.57M | -2.05M | -3.71M | -2.26M | -833.00K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
82 Outperform | £191.46M | 12.30 | 13.06% | 3.05% | -3.66% | 3.28% | |
74 Outperform | £2.55B | 6.64 | 18.69% | 4.16% | -19.08% | 57.32% | |
70 Outperform | £203.93M | 11.75 | 5.09% | 3.73% | 7.94% | -25.81% | |
67 Neutral | £261.59M | 5.94 | 10.69% | ― | 0.50% | ― | |
62 Neutral | $6.84B | 11.41 | 2.80% | 3.87% | 2.70% | -24.58% | |
55 Neutral | £138.20M | ― | -10.58% | ― | -17.31% | 47.33% | |
39 Underperform | £12.27M | ― | -3.56% | 2.22% | -0.42% | -183.34% |